Difference between revisions of "DZI20-135-Case-11"
From MGH Learn Pathology
(Automatic edit to upgrade to new templates) |
(Updating subject, access, and performer) |
||
| Line 11: | Line 11: | ||
|supportingInfo=Meningothelial tumor consistent with known atypical meningioma, viable and without evidence of progression to anaplastic meningioma (permanent dx: recurrent/residual atypical meningioma) | |supportingInfo=Meningothelial tumor consistent with known atypical meningioma, viable and without evidence of progression to anaplastic meningioma (permanent dx: recurrent/residual atypical meningioma) | ||
|reasonCode=72 yo M with multiply recurrent atypical meningioma (s/p multiple resections, radiation, brachytherapy, pembrolizumab, and Avastin) now with imaging concerning for progression | |reasonCode=72 yo M with multiply recurrent atypical meningioma (s/p multiple resections, radiation, brachytherapy, pembrolizumab, and Avastin) now with imaging concerning for progression | ||
| − | |subject= | + | |subject=MGH |
| − | |performer= | + | |performer=NS495 |
|sequence=11 | |sequence=11 | ||
| + | |access=public | ||
}} | }} | ||
{{Media | {{Media | ||
Latest revision as of 16:18, June 21, 2022
/ Case 11
